References
- Sun Y , HaglundTA, RogersAJ, GhanimAF, SethuP. Review: Microfluidics technologies for blood-based cancer liquid biopsies. Analytica Chimica Acta1012, 10–29 (2018).
- Zhang W , XiaW, LvZ, NiC, XinY, YangL. Liquid biopsy for cancer: circulating tumor cells, circulating free DNA or exosomes?Cell. Physiol. Biochem.41(2), 755–768 (2017).
- Cohen JD , LiL, WangYet al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science359(6378), 926–930 (2018).
- Pi C , ZhangM-f, PengX-x, ZhangY-c, XuC-r, ZhouQ. Liquid biopsy in non-small cell lung cancer: a key role in the future of personalized medicine?Exp. Rev. Mol. Diag.17(12), 1089–1096 (2017).
- Melo SA , LueckeLB, KahlertCet al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature523, 177 (2015).
- Yeo JC , Kenry, ZhaoZ, ZhangP, WangZ, LimCT. Label-free extraction of extracellular vesicles using centrifugal microfluidics. Biomicrofluidics12(2), 024103 (2018).
- Babayan A , PantelK. Advances in liquid biopsy approaches for early detection and monitoring of cancer. Genome Med.10(1), 21 (2018).
- Wan JCM , MassieC, Garcia-CorbachoJet al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat. Rev. Cancer17, 223 (2017).